Modi-1, anti-citrullinated neoepitope vaccine, alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal, and ovarian cancers: ModiFy phase I/II basket clinical trial-Report after completion of monotherapy dose-finding
Ottensmeier, C. H. H. Pinato, D. J. J. Armstrong, Anne C Symeonides, S. N. Patel, P. M. Danson, S. Korolewicz, J. Cameron, D. Miller, R. M. Master, F.
Ottensmeier, C. H. H.
Pinato, D. J. J.
Armstrong, Anne C
Symeonides, S. N.
Patel, P. M.
Danson, S.
Korolewicz, J.
Cameron, D.
Miller, R. M.
Master, F.
Citations
Altmetric:
Abstract
Description
Date
2023
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Ottensmeier CHH, Pinato DJJ, Armstrong AC, Symeonides SN, Patel PM, Danson S, et al. Modi-1, anti-citrullinated neoepitope vaccine, alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal, and ovarian cancers: ModiFy phase I/II basket clinical trial-Report after completion of monotherapy dose-finding. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772000466.